OptimizeRx (OPRX) Net Margin (2010 - 2026)

OptimizeRx (OPRX) posted Net Margin of 2.49% for Q1 2026, down 116.02% sequentially from 15.57% in Q4 2025, and up 753.0% YoY from 0.29% in Q1 2025.

OptimizeRx (OPRX) Net Margin (2010 - 2026) Analysis & Trends

OptimizeRx has reported Net Margin for 17 years, with the latest figure at 2.49% in Q1 2026.

Quarterly Net Margin rose 753.0% year-over-year to 2.49% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.37% (up 2270.0% YoY) and the FY2025 annual result came in at 4.69%, up 2652.0% from the prior year.
Net Margin fell to 2.49% in Q1 2026 per OPRX's latest filing, from 15.57% in the prior quarter.
Over five years, Net Margin peaked at 15.57% in Q4 2025 and troughed at 49.2% in Q1 2023.
A 5-year average of 18.01% and a median of 21.31% in 2024 frame the typical range for Net Margin.
The sharpest annual moves came in 2023 and 2025: Net Margin plunged 3973 bps in 2023, then surged 4581 bps in 2025.
Over 5 years, Net Margin stood at 1.66% in 2022, then sank by 2396 bps to 41.38% in 2023, then jumped by 99 bps to 0.24% in 2024, then surged by 6551 bps to 15.57% in 2025, then tumbled by 116 bps to 2.49% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 2.49%, 15.57%, and 2.99% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	29.55%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	2.18%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	19.57%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-11.87%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	20.25%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-22.10%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	12.78%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	15.53%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-24.57%
10	OptimizeRx	164.25 Mn	140.15 Mn	15.69 Mn	-3.43%

Download Data